TG Therapeutics Inc (TGTX)

Current ratio

		Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Total current assets	US$ in thousands	574,069	389,150	360,581	317,943	319,114	208,574	184,783	168,274	182,922	202,560	242,216	330,965	371,779	455,068	535,013	611,740	260,335	280,938	88,016	149,151
Total current liabilities	US$ in thousands	125,114	108,664	99,684	53,720	57,678	72,667	63,076	53,201	36,447	43,326	54,656	65,384	87,655	87,551	92,494	87,554	77,670	67,537	63,118	84,449
Current ratio		4.59	3.58	3.62	5.92	5.53	2.87	2.93	3.16	5.02	4.68	4.43	5.06	4.24	5.20	5.78	6.99	3.35	4.16	1.39	1.77

September 30, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $574,069K ÷ $125,114K
= 4.59

The current ratio of TG Therapeutics Inc has shown fluctuations over the periods provided. The current ratio indicates the company's ability to meet its short-term obligations with its current assets. A higher current ratio is generally preferred as it signifies a stronger ability to cover short-term liabilities.

In the most recent period, as of September 30, 2024, the current ratio stands at 4.59, which is a positive sign indicating the company's current assets are 4.59 times higher than its current liabilities. This suggests a strong liquidity position for TG Therapeutics Inc, reflecting its ability to easily cover its short-term obligations.

Looking at the historical trend, the current ratio has shown variability with some periods showing a notably high current ratio (e.g., December 31, 2023, and December 31, 2022), indicating a strong liquidity position during those times. However, there are instances where the current ratio was relatively low, such as March 31, 2020, and June 30, 2023, suggesting potential liquidity challenges in those periods.

Overall, the current ratio of TG Therapeutics Inc has generally been healthy, with fluctuations over time. Investors and stakeholders should continue to monitor this ratio along with other financial indicators to assess the company's financial health and liquidity position accurately.